Oncology News | pharmaphorum

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J goes after another FDA approval for a cancer bispecific

Johnson & Johnson's much-touted crop of bispecific antibodies for cancer generated its first commercial product in May, and the drugmaker has now filed for FDA approval of a second cand

News

FDA gives Daiichi Sankyo's HER3 drug a breakthrough tag

Daiichi Sankyo has been granted breakthrough status by the FDA for patritumab deruxtecan, a HER3-targeted antibody-drug conjugate (ADC) in clinical trials for lung cancer.

News

Sanofi buys US immuno-oncology biotech Amunix for $1 billion

Sanofi has bolstered its immuno-oncology pipeline with a $1 billion agreement to acquire Amunix Pharma of the US – its fourth bolt-on deal of 2021.

News

Novartis taps immuno-oncology partner BeiGene for TIGIT drug

Novartis has joined the ranks of big pharma companies developing TIGIT-targeted drugs for cancer, and found its candidate in an existing partner, Chinese biotech BeiGene.

News

ASH: Trial backs Gilead's Yescarta CAR-T in first-line lymph...

Gilead Sciences has taken a big step towards positioning its CAR-T therapy Yescarta as an option for previously-untreated large B cell lymphoma (LBCL) with updated results from the ZUMA-12

News

ASH: Gilead, BMS CAR-Ts square off in relapsed lymphoma

A pair of trials have suggested that CAR-T therapies could offer an improved option for patients with large B cell lymphoma (LBCL) who have relapsed after or haven't responded to first-line

J&J goes after another FDA approval for a cancer bispecific

FDA gives Daiichi Sankyo's HER3 drug a breakthrough tag

Sanofi buys US immuno-oncology biotech Amunix for $1 billion

Novartis taps immuno-oncology partner BeiGene for TIGIT drug

ASH: Trial backs Gilead's Yescarta CAR-T in first-line lymph...

ASH: Gilead, BMS CAR-Ts square off in relapsed lymphoma

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks